Estrogens and Male Lower Urinary Tract Dysfunction
- 10 July 2015
- journal article
- review article
- Published by Springer Nature in Current Urology Reports
- Vol. 16 (9) , 61
Abstract
Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common clinical problems in urology and affect the majority of men at some time during their lives. The development of BPH/LUTS is associated with an increased ratio of estrogen to androgen levels, and this ratio, when mimicked in a variety of animals, induces BPH and lower urinary tract dysfunction (LUTD). While the precise molecular etiology remains unclear, estrogens have been implicated in the development and maintenance of BPH. Numerous endogenous and exogenous estrogens exist in humans. These estrogens act via multiple estrogen receptors to promote or inhibit prostatic hyperplasia and other BPH-associated processes. The prostate is an estrogen target tissue, and estrogens directly and indirectly affect growth and differentiation of prostate. The precise role of estrogen action directly affecting prostate growth and differentiation in the context of BPH is an understudied area and remains to be elucidated. Estrogens and selective estrogen receptor modulators (SERMs) have been shown to promote or inhibit prostate proliferation illustrating their potential roles in the development of BPH as therapy. More work will be required to identify estrogen signaling pathways associated with LUTD in order to develop more efficacious drugs for BPH treatment and prevention.Keywords
This publication has 58 references indexed in Scilit:
- Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulatorsMolecular Systems Biology, 2013
- Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic reviewBJU International, 2012
- Androgens and estrogens in benign prostatic hyperplasia: Past, present and futureDifferentiation, 2011
- Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract SymptomsJAMA, 2011
- Food Packaging and Bisphenol A and Bis(2-Ethyhexyl) Phthalate Exposure: Findings from a Dietary InterventionEnvironmental Health Perspectives, 2011
- Loss of epithelial oestrogen receptor α inhibits oestrogen‐stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout modelsThe Journal of Pathology, 2011
- Progression of Lower Urinary Tract Symptoms in Older Men: A Community Based StudyJournal of Urology, 2010
- A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cellsReproductive Biology and Endocrinology, 2009
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk ReductionJournal of Clinical Oncology, 2009
- The ins and outs of GPR30: A transmembrane estrogen receptorThe Journal of Steroid Biochemistry and Molecular Biology, 2008